Healthcare
How Suffolk Construction and Takeda Pharmaceutical Drive Innovation with Data and Startup Investments
One of the mainstage sessions at our recent Impact conference in Boston featured Jit Kee Chin, Chief Technology Officer at Suffolk Construction, and Gabriele Ricci, Chief Data and Technology Officer at Takeda Pharmaceuticals. Here are seven key themes they discussed…
11 AI Trends for Healthcare Heading into 2026
Healthcare AI trends according to the Mayo Clinic, Oracle, UCLA Health, and a former partner at Mass General Brigham’s AI and Digital Innovation Fund.
How Covetrus is Applying AI to Help Veterinary Practices Be More Productive
Just as AI is transforming human healthcare, veterinary medicine is undergoing a similar shift. Animal health company Covetrus is integrating AI into its platform to streamline workflows, enhance clinical decision-making, and improve patient care. Chief Product and Technology Officer Scot Gillespie explains…
Aligning Innovation to Top Priorities at Blue Cross Blue Shield of Massachusetts
“I find that the best way to get strong leadership support is to be the first person to welcome people to the organization, to be the first person to educate them on what innovation is, to be the first person that sees eye to eye with them on how innovation might work for them,” says David Creane. Read more from our interview…
Driving Patient Care Innovation at UC San Diego Health
“To embed daily innovation as part of our culture,” says Ashley Gambhir, “we created a mission statement: We want to have 14,000 problem solvers that relentlessly improve care while loving their jobs. We started a management system to encourage daily input by asking, ‘What ideas do you have?'” Read more from our interview…
New Research Questions the Value of ‘Quick and Dirty’ Prototypes
A new research report has shown that in markets with complex ecosystems (think healthcare), the use of lean and agile methodologies may be less helpful than previously thought.
Finding New Efficiencies with GenAI at EMD Serono
We talk to the Head of Data-Driven Innovation and Analytics at the biopharma company about leveraging new technologies like generative AI, and how his team is working to create value.
My Advice: Overcoming the Challenges to Innovation in Regulated Industries
In any highly-regulated industry, well-intentioned rules can often hinder innovators from advancing great ideas. How do you overcome that? Here’s advice from an innovator at AstraZeneca.
Inside a $5B Health System’s ‘AlphaLab’: Structure, Priorities, Metrics and More
We talk with Dr. Jeffrey Cohen, Chief Physician Executive for Community Health and Innovation at Pittsburgh-based Allegheny Health Network, a $5 billion medical system that operates 14 hospitals and more than 200 primary- and specialty-care practices.
How Syneos Health is Building AI Solutions for Clinical Trials
Right now, says Ilya Vedrashko, Vice President of AI Products, the focus when it comes to creating and deploying new AI software “is on creating the solutions for Syneos [employees], and upgrading a lot of the internal processes with the solutions.” Eventually, the company may offer some of the software it develops to client companies.
Generative AI First Movers in 2024: Examples from Five Industries
A 2024 rundown of recent notable generative AI projects, broken down by industry. Includes Volkswagen, Pfizer, Starbucks, and more…
Inside J&J’s Approach to New Company Creation
The healthcare giant’s approach to new venture creation, in partnership with outside venture capital firms, got rolling in 2021. We talk with Sanjay Mistry, VP of Venture Investments and New Company Creation…
Nihon Kohden Innovation Center CEO on the ‘Negative Stage Gate’ Process
As part of our latest research report, Building a Productive Innovation Portfolio, we spoke with Weisner, Nihon Kohden Innovation Center’s President and CEO, to get his advice on engaging the necessary stakeholders for innovation activities, hear about what he calls “the negative stage gate system,” and understand how his team’s governance structure has changed over the past few years.
What is the ‘Love Metric’? Advocate Health’s VP of Enterprise Innovation Explains
Todd Dunn, VP of Enterprise Innovation for Advocate Health, dives deep on standing up an innovation program while including perspectives from other business units; what he calls the ‘love metric’; and more as part of an interview for our new research report, Building a Productive Portfolio.
Best Buy Health President on Artificial Intelligence in Health Care
Deborah DiSanzo, President of Best Buy Health, shares her thoughts on how artificial intelligence will affect patients and healthcare professionals; gives commentary on ChatGPT; and more.
Inside CareQuest’s Accelerator, Which Seeks to Improve Health Equity and Access
CareQuest Innovation Partners, an organization focused on oral health transformation, teamed up with MATTER, a healthcare incubation and innovation organization to create SMILE Health, a first-of-its-kind oral health accelerator. SMILE Health is focused around increasing access and equity in oral health for more positive public health outcomes. Kirill Zaydenman, VP of Innovation at CareQuest discussed the accelerator, its upcoming Demo Day, and what’s next for the five companies that have participated.
Healthcare Leaders Discuss the Biggest Trends of 2022
At our most recent event, we gathered several healthcare leaders to chat about the most impactful trends in the industry this year. Prashant Srivastrava of Innosight, Caroline Pepek of MassBio, and Julia Jackson of Takeda shared their thoughts. One of the most impactful trends? Consumer expectations for a customized experience.
How AI and Decentralized Clinical Trials are Changing Biopharma
“As humans, we have limitations in being able to integrate and synthesize and look at data,” says venture capitalist John Orloff, formerly Global Head of R&D at Alexion Pharmaceuticals. “I think AI and machine learning technology will allow us to make better decisions and choices, and give us new insights into how to approach certain diseases.” More from Orloff inside…
How 3M Reorganized R&D — and How the Company Tracks R&D Impact
In early 2020, 3M decentralized its operating model to give the presidents of its four business groups more autonomy over R&D. We talk to SVP Cordell Hardy about how it started, and how it’s going.
Member Spotlight: Claire Johnsen, Hallmark Care Homes & Savista Developments
Claire Johnsen is Head of Innovation of Hallmark Care Homes and Savista Developments, a family-run company that operates 19 eldercare facilities in the UK. We spoke with Johnsen as part of our IL Member Spotlight series, which profiles our members.
Why ‘AgeTech’ is a $9 Trillion Sector You Shouldn’t Ignore
Rick Robinson, VP of Product and Startup Engagement at AARP, makes a case for opportunities in the growing AgeTech sector.
How Pharma Distributor AmerisourceBergen Prioritizes and Pilots Emerging Tech
One key is to success with emerging tech is working closely with customers, says SVP of Strategy and Innovation Jason Dinger: “Sometimes, we identify hidden value where a customer sees a way to deploy a technology that we didn’t see.”
Inside athenahealth’s Interactive Telehealth Dashboard
athenahealth’s Vice President of Research and Editorial Strategy shares why her team created an interactive telehealth dashboard that helps to collect and analyze consumer insights…
Why CVS Created a Dedicated Venture Fund
During the COVID-19 pandemic, healthcare providers around the globe sought digital solutions, and patients sought at-home options for what would have been in-person visits. Vijay Patel, Partner & Co-founder of CVS Health Ventures and Senior Director of Business Development of CVS Health Digital health and virtual care are two areas of focus for CVS Health […]
How the Pandemic Accelerated Digital Adoption in Healthcare
During a panel at the World Medical Innovation Forum, leaders from Bayer AG, Novartis Gene Therapy, and GE Healthcare shared how pandemic innovation has allowed the healthcare industry to make strides.
Four Tips on How R&D Can Work Better with Design
David Dombrowski of pharmaceutical company GlaxoSmithKline (GSK) considers being a translator between designers and innovators one of his main responsibilities. He shares four tips for innovators.
How Dana-Farber Leverages Partnerships to Advance Cancer Treatments
Lesley Solomon, Senior Vice President and Chief Innovation Officer at Dana-Farber Cancer Institute, discusses how her team utilizes partnerships to get new treatments to patients faster.
Lundbeck’s CEO on Developing Breakthrough Medications
How do CEOs determine focus areas and allocate budget to R&D initiatives? Deborah Dunsire, CEO of Lundbeck — a phamaceutical company specializing in neurology and psychology — explains.
Corporate Innovators Talk Cost-Cutting and the Need to Reinvest in Innovation
During a recent conversation on the Clubhouse app, corporate innovators discussed weathering the COVID recession, pursuing breakthrough ideas, and corporate venture capital programs.
How Moderna’s CDO Leverages Software & Automation for Speed
Moderna’s Chief Digital and Operational Excellence Officer shares insights on how the company’s digital infrastructure supported the design and production of the company’s COVID-19 vaccine.
Member Spotlight: Tom Wagner, AstraZeneca
Tom Wagner is the Director of Digital Research, Knowledge Management & Market Intelligence at AstraZeneca. We spoke with Wagner as part of our IL Member Spotlight series, which profiles our members.
Takeda’s CTO on Building Technology Roadmaps
How do Chief Technology Officers build roadmaps to implement new technologies? And, how do they leverage data to innovate? Leo Barella, Chief Technology Officer at Takeda Pharmaceutical Company, explains.
How Bayer’s Open Innovation Chief Overcomes Metric Challenges
Chandra Ramanathan, Global Head of Pharma R&D Open Innovation at Bayer, shares insights on what metrics his team measures, how he overcomes challenges in reporting…
How Illumina is Building a Genomics Ecosystem
Amanda Cashin is the Global Head of the Illumina Accelerator, a startup accelerator that is dedicated to making human genome sequencing more accessible and useful. We spoke with Cashin about recent accomplishments.
Making Ideas Pay at Atrium Health
In this Master Class, Todd Dunn, Vice President of Innovation at Atrium Health and Tad Haas, Executive Vice President at edison365 discuss how Atrium Health designs for impact.
Empowering an AI-First Organization with Anthem’s Chief Digital Officer
How can AI and machine learning provide patients with personal, preemptive healthcare? Rajeev Ronanki, Chief Digital Officer and Senior Vice President of Anthem, explains.
Building a Culture of Innovation at Delta Dental
How can organizations build a culture of innovation and effectively create buy-in for change? Sarah Chavarria, the Chief People Officer of Delta Dental, explains.
Building, Scaling & “Unbossing” Innovation at Novartis’ Genesis Labs
Ian Hunt and Aimee Reynolds of Novartis’ Genesis Labs share insights on developing an effective innovation ecosystem that ensures that the best ideas bubble up to the top.
Preparing for Vaccine Distribution, Navigating Pivots at HCA
Chip Blaufuss of HCA Healthcare discusses his team’s COVID-19 preparations at the start of 2020 and getting ready for vaccine distribution in 2021.
















































